Skip to main content

Month: January 2025

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

– Total Revenue Increases 5% Year-Over-Year – Achieves Sustained Revenue Growth, Improved Gross Margins, and Significant Cost Savings IRVINE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2025 ended November 30, 2024. Key Highlights:Direct-to-Consumer Launch of inFoods® IBS TestPatients can now order the inFoods® IBS test directly from www.infoodsIBS.com without the need for a doctor’s visit. With a simple, at-home finger-prick blood sample, this non-invasive and personalized test identifies trigger foods that cause IBS symptoms such as bloating and gastrointestinal discomfort. Physician oversight ensures a safe and convenient path to...

Continue reading

Form 8.3 – [THRUVISION GROUP PLC – Opening Disclosure – 14 01 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree THRUVISION GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

National Bank of Egypt Enhances Enterprise Security with Multi-Factor Authentication and Single Sign-On Solutions from BIO-key

CAIRO, Egypt and HOLMDEL, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) solutions featuring multi-factor authentication (MFA) and Single Sign-On (SSO) technologies, announced today that the National Bank of Egypt (NBE), Egypt’s largest financial institution, is deploying BIO-key’s PortalGuard identity and access management platform and an industry-leading Identity Governance solution. This strategic project is being implemented in partnership with Raya Information Technology, a trusted reseller certified in BIO-key technologies, as part of NBE’s ongoing efforts to deploy best-in-class IT solutions for its 30,000 employees. The initiative leverages technology PortalGuard’s unified IAM advanced Multi-Factor Authentication and Single...

Continue reading

BTCS Utilizes Rocket Pool to Drive Revenue Growth and Enhance Margins

Commitment to Growth in Ethereum Infrastructure Silver Spring, MD, Jan. 15, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, today announced the deployment of its Scaled Validator Implementation Plan. This strategic initiative is designed to drive revenue growth and improve margins, aligning with BTCS’s commitment to innovation and operational efficiency in the blockchain sector. Over the past five months, BTCS has conducted an extensive due diligence process on Rocket Pool, a decentralized Ethereum-based liquid staking protocol. This evaluation included a thorough assessment of auditability, compliance, cybersecurity, infrastructure integrity, and potential business risks and rewards to ensure a secure and scalable validator implementation. As part...

Continue reading

Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care

Vida to offer cardiometabolic solutions including GLP-1s and other anti-obesity medications on the Amwell platform BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) — Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of the clinical programs portfolio on the Amwell platform. The program, Amwell Cardiometabolic Care Powered by Vida, will be available to Amwell’s expansive client footprint of health plans and employers. Clients will be able to offer their members access to a suite of cardiometabolic care, including obesity, diabetes prevention and management, and behavioral health support. The program will tailor care based on social factors such as food security, financial barriers, cultural norms, and beliefs. Vida’s services are available...

Continue reading

LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million

•  Streamlined Operations and NYC Focus Set the Stage for 2025 Growth •  RevPAR Gains and Optimized Portfolio Highlight Operational Momentum MIAMI, Jan. 15, 2025 (GLOBE NEWSWIRE) — LuxUrban Hotels Inc. (Nasdaq: LUXH), a hospitality company that leases entire hotels on a long-term basis, manages these hotels, and rents out rooms to guests in the properties it leases, today provided a comprehensive corporate update, highlighting recent business achievements and sharing its 2025 revenue guidance and strategic milestones. It has been a transformative year for LuxUrban Hotels, Inc., marked by substantial progress in improving the business, streamlining operations, and building a strong foundation for 2025 growth and profitability. 2024 Business Highlights and Achievements Over the past year, LuxUrban has taken deliberate steps to improve...

Continue reading

Synaptics to Report Second Quarter Fiscal 2025 Results on February 6, 2025

SAN JOSE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced that it will report financial results for the second quarter of fiscal 2025 on Thursday, February 6, 2025, after the market closes. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), during which management may discuss forward-looking information. To participate on the live call, analysts and investors should pre-register at Synaptics Q2 FY2025 Earnings Call Registration.  https://register.vevent.com/register/BI158a46a65d6743c6b0846d8242dcea87 Registrants will receive dial-in information and a unique passcode to access the call. We encourage participants to dial-in into the call ten minutes ahead of scheduled time. Synaptics will also offer a live and archived webcast...

Continue reading

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

New hire set to drive clinical development and U.S. commercialization of the continuous blood glucose monitor for people with diabetes RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Ted Williams has been named Vice President of Regulatory Affairs, effective immediately. Mr. Williams has nearly 25 years of experience and a proven track record of successful management of Regulatory Affairs and Quality Assurance for highly complex Class III medical devices including active, long term implantable continuous glucose monitors (“CGM”), drug/device combination products, in-dwelling catheter based endovascular temperature...

Continue reading

SWA Lithium Drills New Smackover Well and Conducts Extensive Reservoir Testing Program at South West Arkansas Lithium Project

SWA Lithium and Contractors Drill a New Well into the Smackover Formation to Complete Understanding of the Reservoir for Production Modelling Additional Testing Program in 2023 Wells is Designed to Improve Understanding of Formation and Revise the Brine Chemistry for the First Phase of Production LOUISVILLE, Ark., Jan. 15, 2025 (GLOBE NEWSWIRE) — SWA Lithium, the Joint Venture between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) and Equinor ASA (“Equinor”) which is developing the South West Arkansas Project (“SWA” or the “Project”), is pleased to announce that it has successfully commenced drilling a new well into the Smackover Formation at the Project. The well is currently at a depth of approximately 8,000’ below surface (2,438 m), and has a targeted total depth of 9,600’ (2,926...

Continue reading

SoundThinking Partners with Local New Orleans Organizations to Build Bikes for Children

NEW ORLEANS, Jan. 15, 2025 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public safety technology provider, hosted a community bike building event at the Hyatt Regency Hotel on Tuesday, January 7, 2025 in partnership with the New Orleans Police Department (NOPD) and the New Orleans Recreation Development Commission (NORD). As part of dedicated programming during the company’s annual all-hands retreat, approximately 275 SoundThinking employees, including the company’s senior executives, worked together—alongside 10 NOPD officers—to build bikes for children ages 5 to 9. Each team was given the necessary bike parts—including frames, pedals, and wheels—to assemble a working bicycle. The teams wrote custom messages to the recipients of each bicycle before handing them over to NORD for delivery to children, along with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.